Literature DB >> 10383512

Survey on repeat prescribing for acid suppression drugs in primary care in Cornwall and the Isles of Scilly.

R Boutet1, M Wilcock, I MacKenzie.   

Abstract

BACKGROUND: Repeat prescriptions for acid suppression therapy represent an important burden on health care resources. AIM: To determine the prevalence of acid suppression therapy and its indications by general practitioners (GPs) in a larger sample of practices than previous studies.
METHOD: Practices in Cornwall and the Isles of Scilly were invited to identify the number of patients on repeat prescription for acid suppression drugs in their practice, to review the indication for treatment in a sample of 50 patients, and to indicate the mode of review of these patients.
RESULTS: Out of 77 practices, 42 (55%) participated in the study. Overall, 5% of patients were authorized to receive a repeat prescription for acid suppression drugs. Repeat rates varied between practices, from 1.68% to 11.11%. Repeat rates increased with age and were higher in men than in women. Only 41% of patients had a proven diagnosis of gastro-oesophageal reflux disease or peptic ulcer. A review of notes was the most frequent way (36%) stated by GPs to review acid suppression therapy.
CONCLUSION: The repeat rate found in our study was higher than that found in previous studies. A high proportion of older patients in Cornwall, as well as a continuing increase in the prescription of acid suppression drugs, may account for these results.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383512     DOI: 10.1046/j.1365-2036.1999.00524.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  9 in total

1.  Inadequate use of acid-suppressive therapy in hospitalized patients and its implications for general practice.

Authors:  Raffaella Scagliarini; Elena Magnani; Antonino Praticò; Renato Bocchini; Paola Sambo; Paolo Pazzi
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

2.  Endoscopic ultrasonography features of gastric mucosal cobblestone-like changes from a proton-pump inhibitor.

Authors:  Shuichi Miyamoto; Takahiko Kudo; Mototsugu Kato; Kana Matsuda; Satoshi Abiko; Momoko Tsuda; Takeshi Mizushima; Keiko Yamamoto; Shoko Ono; Yuichi Shimizu; Naoya Sakamoto
Journal:  Clin J Gastroenterol       Date:  2017-03-06

3.  Improving prescribing for older patients - 'Yes S-I-R-E!'

Authors:  Ting Ting Selina Cheong; Sharifah Munirah Alhamid; Fu Yin Li; Swee Tee Wendy Ang; Kim Hwa Jim Lim
Journal:  Singapore Med J       Date:  2018-11-29       Impact factor: 1.858

Review 4.  The role of protein digestibility and antacids on food allergy outcomes.

Authors:  Eva Untersmayr; Erika Jensen-Jarolim
Journal:  J Allergy Clin Immunol       Date:  2008-06       Impact factor: 10.793

5.  Prevalence of anti-ulcer drug use in a Chinese cohort.

Authors:  Tzeng-Ji Chen; Li-Fang Chou; Shinn-Jang Hwang
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

6.  A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long-Term Safety.

Authors:  E Dubcenco; P M Beers-Block; L P Kim; P Schotland; J G Levine; C A McCloskey; E D Bashaw
Journal:  Clin Transl Sci       Date:  2017-06-15       Impact factor: 4.689

7.  Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.

Authors:  Shuichi Miyamoto; Mototsugu Kato; Kana Matsuda; Satoshi Abiko; Momoko Tsuda; Takeshi Mizushima; Keiko Yamamoto; Shoko Ono; Takahiko Kudo; Yuichi Shimizu; Kanako C Hatanaka; Izumi Tsunematsu; Naoya Sakamoto
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

8.  Attitude and knowledge of Saudi community pharmacists towards use of proton pump inhibitors.

Authors:  Abdulaziz Alhossan; Ziyad Alrabiah; Sultan Alghadeer; Salmeen Bablghaith; Syed Wajid; Mohammed Al-Arifi
Journal:  Saudi Pharm J       Date:  2018-11-07       Impact factor: 4.330

Review 9.  Long-term management of GERD in the elderly with pantoprazole.

Authors:  Carlo Calabrese; Anna Fabbri; Giulio Di Febo
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.